Chemwerth, Inc. acquired 10% stake in Mahi Drugs Private Limited from SMS Lifesciences India Limited (NSEI:SMSLIFE) on November 30, 2021. The deal is subject to approval from SMS Lifesciences India Limited board. As of November 30, 2021 SMS Lifesciences India Limited board approved the deal. the Company has received an amount of INR 75 million towards sale consideration of 10% its stake in M/s. Mahi drugs Private Limited (Wholly owned Subsidiary) i.e 4,71,510 Shares @ INR 159/- per share. Balance consideration of INR 0.4 million was received in second week of January, 2022 and transfer of said shares is under process.

Chemwerth, Inc. completed the acquisition of 10% stake in Mahi Drugs Private Limited from SMS Lifesciences India Limited (NSEI:SMSLIFE) on November 30, 2021.